Progen Co Ltd

296160

Company Profile

  • Business description

    Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

  • Contact

    172 Magokjungang-ro
    7th Floor, Bio Innovation Park
    Gangseo-gu
    Seoul
    KOR

    T: +82 260982800

    http://www.progen.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    50

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,960.203.30-0.04%
CAC 407,800.8833.70-0.43%
DAX 4023,970.36247.14-1.02%
Dow JONES (US)44,837.5664.36-0.14%
FTSE 1009,081.4438.87-0.43%
HKSE25,354.69207.44-0.81%
NASDAQ21,178.5870.270.33%
Nikkei 22540,628.99369.28-0.90%
NZX 50 Index12,936.4125.670.20%
S&P 5006,389.771.130.02%
S&P/ASX 2008,698.801.100.01%
SSE Composite Index3,602.284.340.12%

Market Movers